The coming AI and data revolution in life sciences

The coming AI and data revolution in life sciences

Pharmafield is proud to announce a new, free webinar called ‘The coming AI and data revolution in healthcare’, where a panel (including Janssen, OKRA and the German Federal Ministry of Health) will discuss why Artificial Intelligence has emerged as a promising technology to revolutionise the market access and pricing function in life sciences.

The webinar will look at strategies during uncertain times. Which is the best way to go? Is it to just stick to what you know, and pray that it keeps working? Or do we need a more open-minded approach, where we try new things and quickly evaluate whether they worked?

FREE WEBINAR: The coming AI and data revolution in healthcare
                  Why artificial intelligence has emerged as a promising technology to                      revolutionise the market access and pricing function in life sciences.

Thursday 10th December | 1400 London / 1500 Paris / 0900 New York


It can be tempting to bury your head in the sand. Business continuity was the first priority when lockdown began. And humans often find change frightening, especially when there’s a lot at stake – like there often is in life sciences.

That’s why we need computers. Computers have one quality which is quite different from their human counterparts – they are tireless. They can go on forever. Which is why there is so much potential in artificial intelligence, especially during such times of uncertainty, to try and test multiple hypotheses in a very short period of time.

Making market access enticing

If it wasn’t for COVID-19, pharmaceutical access would have likely dominated a lot of headlines in 2020. Achieving the desired ‘submission outcome’ – a combination of commercial need, payer tolerance, creative dossier design, patient value and public perception – is something which takes professionals several months, if not years, to get right. It requires hundreds of data sources to be crunched – everything from clinical trial data to population forecasting.

Sounds complicated, right? It is. But now, with artificial intelligence, forming an evidence lead opinion can take a matter of minutes rather than months, once all of the key data is fed into the computer.

Data to the rescue

When deployed correctly, artificial intelligence is a reliable, trustworthy companion that uses data to make the best recommendations. The more data, and the more diverse that data, the better. But not all data is the same, and not all data is able to train AI algorithms.

Getting the right sort of data requires us to build collaborations with different data owners to create more complete, diverse pictures. Data collected in this way will enable better decision making and identify further opportunities for automation and deployment of AI, where it delivers the best possible value.

The European Health Data Space is an exciting collaborative project which is designed to provide greater access to different types of health data, aiming to support healthcare delivery, research and policy making. It offers a valuable opportunity to drive our healthcare towards a more effective, sustainable and personalised approach.

Join to learn more

The webinar will also cover the European Health Data Space and the impact it will have in the coming years, allowing a unified access to different types of health data across the continent.

Go to to find out more.